We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Investment Ideas feature highlights: Boston Scientific, Meta Platforms and Microsoft
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 2, 2025 – Today, Zacks Investment Ideas feature highlights Boston Scientific (BSX - Free Report) , Meta Platforms (META - Free Report) and Microsoft (MSFT - Free Report) .
These 3 Stocks Soared Following Quarterly Results
The 2025 Q1 earnings cycle is in full swing, with many companies on the docket to reveal quarterly results in the coming weeks.
Guidance is a key factor in this cycle, more so than we’ve seen in recent periods due to the overall level of uncertainty brought about by recent tariff announcements and other economic developments.
So far, several companies, including Boston Scientific, Meta Platforms and Microsoft, have all delivered positive results, with each seeing a bullish share reaction post-earnings. Let’s take a closer look at the positivity.
BSX Raises Guidance
Boston Scientific exceeded both top and bottom line expectations handily, delivering a strong 12% EPS beat alongside sales that were 2.3% ahead of expectations. Upgraded current-year guidance has provided a notably bullish outlook, with the stock also now sporting a coveted Zacks Rank #2 (Buy).
Analysts have adjusted their current year sales and EPS expectations accordingly following the favorable print, with BSX expected to see 16% EPS growth on 17% higher sales. The stock sports a Style Score of ‘B’ for Value.
Strong segment performance has aided the company’s bright outlook, leading to the above-mentioned guidance upgrade in an overall uncertain environment.
Meta Ad Revenue Remains Robust
Meta Platforms continued to fire on all cylinders throughout its latest period, again exceeding our consensus EPS and sales expectations handily and posting strong growth. Sales grew an impressive 16% year-over-year thanks to strong Advertising results, which totaled a solid $41.3 billion.
Notably, the company’s average price per ad climbed 10% year-over-year, with its family daily active people (DAP) also seeing a 6% move higher year-over-year. The company’s user base growth has continued to be outstanding, providing many clear benefits.
Microsoft Cloud Impresses
Concerning headline figures in Microsoft’s release, EPS of $3.46 and sales of $70.0 billion both handily exceeded our consensus expectations, continuing its recent streak of better-than-expected results. Sales grew an impressive 13% year-over-year, whereas EPS climbed 18%.
Unsurprisingly, Microsoft Cloud and AI strength drove the strong results, with Microsoft Cloud revenue soaring 20% year-over-year to $42.4 billion. Demand has remained strong for the tech titan, with commentary alluding to the trend remaining for years to come.
Importantly, its Intelligent Cloud (includes Azure) revenue totaled a strong $26.8 billion, up 21% from the year-ago period. The Intelligent Cloud results snapped a small streak of misses on the metric.
Bottom Line
The 2025 Q1 cycle continues to roll along, with all three stocks above seeing a nice move higher following their respective quarterly releases.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Investment Ideas feature highlights: Boston Scientific, Meta Platforms and Microsoft
For Immediate Release
Chicago, IL – May 2, 2025 – Today, Zacks Investment Ideas feature highlights Boston Scientific (BSX - Free Report) , Meta Platforms (META - Free Report) and Microsoft (MSFT - Free Report) .
These 3 Stocks Soared Following Quarterly Results
The 2025 Q1 earnings cycle is in full swing, with many companies on the docket to reveal quarterly results in the coming weeks.
Guidance is a key factor in this cycle, more so than we’ve seen in recent periods due to the overall level of uncertainty brought about by recent tariff announcements and other economic developments.
So far, several companies, including Boston Scientific, Meta Platforms and Microsoft, have all delivered positive results, with each seeing a bullish share reaction post-earnings. Let’s take a closer look at the positivity.
BSX Raises Guidance
Boston Scientific exceeded both top and bottom line expectations handily, delivering a strong 12% EPS beat alongside sales that were 2.3% ahead of expectations. Upgraded current-year guidance has provided a notably bullish outlook, with the stock also now sporting a coveted Zacks Rank #2 (Buy).
Analysts have adjusted their current year sales and EPS expectations accordingly following the favorable print, with BSX expected to see 16% EPS growth on 17% higher sales. The stock sports a Style Score of ‘B’ for Value.
Strong segment performance has aided the company’s bright outlook, leading to the above-mentioned guidance upgrade in an overall uncertain environment.
Meta Ad Revenue Remains Robust
Meta Platforms continued to fire on all cylinders throughout its latest period, again exceeding our consensus EPS and sales expectations handily and posting strong growth. Sales grew an impressive 16% year-over-year thanks to strong Advertising results, which totaled a solid $41.3 billion.
Notably, the company’s average price per ad climbed 10% year-over-year, with its family daily active people (DAP) also seeing a 6% move higher year-over-year. The company’s user base growth has continued to be outstanding, providing many clear benefits.
Microsoft Cloud Impresses
Concerning headline figures in Microsoft’s release, EPS of $3.46 and sales of $70.0 billion both handily exceeded our consensus expectations, continuing its recent streak of better-than-expected results. Sales grew an impressive 13% year-over-year, whereas EPS climbed 18%.
Unsurprisingly, Microsoft Cloud and AI strength drove the strong results, with Microsoft Cloud revenue soaring 20% year-over-year to $42.4 billion. Demand has remained strong for the tech titan, with commentary alluding to the trend remaining for years to come.
Importantly, its Intelligent Cloud (includes Azure) revenue totaled a strong $26.8 billion, up 21% from the year-ago period. The Intelligent Cloud results snapped a small streak of misses on the metric.
Bottom Line
The 2025 Q1 cycle continues to roll along, with all three stocks above seeing a nice move higher following their respective quarterly releases.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.